Augusta University Pediatric Cancer

NCI Designated Program
Augusta University
Minority Based Community Clinical Oncology Program (MB-CCOP)
Augusta, Georgia

The Augusta University, formerly Georgia Regents University, Cancer Center Minority-Based Community Clinical Oncology Program (MB-CCOP) is designed to increase the availability of state-of-the-art cancer treatment and research to minority individuals in their own communities. Establishment of an operational base in this part of Georgia for extending cancer clinical trials and cancer prevention aims to reduce cancer incidence, morbidity, and mortality in minority populations.

The program was created by the National Cancer Institute (NCI) in 1983 and awarded to Augusta University (formerly known as Georgia Regents University, the Medical College of Georgia or MCG and Georgia Health Sciences University) in August of 2004. The principal investigator is Anand P. Jillella, MD. The Grant describes the organizational and operational plans intended to provide structure for the effective implementation of multidisciplinary research. African-Americans comprise 42% of newly diagnosed cancer patients at Augusta University. Adult and pediatric cancer clinical trial programs at Augusta University have been successfully enrolling minorities to clinical trials (40% of patients entered are African-Americans). Ultimately, success of the MB-CCOP depends upon the joint efforts of three departments: Adult Hematology/Oncology, Pediatric Hematology/Oncology, and Family Medicine.

(706) 721-1660
http://www.augusta.edu/cancer/

Treatment Sites in Georgia

Primary Location

1446 Harper Street
5th Floor
Augusta, GA 30912
706-721-5437 (p)
www.augustahealth.org

driving directions

Clinical Trials in Georgia

National Wilm's Tumor Study Late Effects
Cancer Type: Wilms Tumor
Study Coordinator: Kimberly Gray - (706)-721-3626


Phase III Partially Randomized Study of Risk-Adapted Chemotherapy in Pediatric Patients With Newly Diagnosed Standard-Risk B-Precursor Acute Lymphoblastic Leukemia
Cancer Type: Acute Lymphoblastic Leukemia
Study Coordinator: Kimberly Gray - (706)-721-3626


Phase III Randomized Study of Adding Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide to Standard Chemotherapy in Patients With Non-Metastatic Extracranial Ewing Sarcoma
Cancer Type: Brain Cancer
Study Coordinator: Kimberly Gray - (706)-721-3626


Protocol for the Enrollment on the Official COG Registry, The Childhood Cancer Research Network (CCRN) Children's Oncology Group
Cancer Type: Multiple Primaries
Study Coordinator: Kimberly Gray - (706)-721-3626


Research Study of Clinical, Genetic, and Biological Factors as Prognostic Values in Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Cancer Type: Neuroblastoma
Study Coordinator: Kimberly Gray - (706)-721-3626


Study of Collection and Banking of Specimens From Pediatric Patients With Brain Tumors
Cancer Type: Germ Cell Tumor
Study Coordinator: Kimberly Gray - (706)-721-3626


Study of Key Late-Occurring Complications in Childhood Cancer Survivors
Cancer Type: Multiple Primaries
Study Coordinator: Kimberly Gray - (706)-721-3626


Study of Renal Tumors in Pediatric Patients
Cancer Type: Kidney Cancer
Study Coordinator: Kimberly Gray - (706)-721-3626


Study to Collect and Characterize Tissue Specimens From Patients With Rhabdomyosarcoma Or Non-Rhabdomyosarcoma Soft Tissue Sarcoma
Cancer Type: Bone and Soft Tissue (including Sarcoma)
Study Coordinator: Kimberly Gray - (706)-721-3626